Scilex (SCLX) said Thursday that it has closed an exchange of $200 million worth of common stock of its majority owned subsidiary Semnur Pharmaceuticals for $200 million in Bitcoin.
The company said the transaction with an institutional investor included 12.5 million Semnur shares at $16 per share.
Shares of Scilex were up 1% in recent premarket activity Thursday.